Johanan Locker - Israel Corp Director
| ILCO Stock | ILA 88,800 800.00 0.91% |
Director
Mr. Johanan Locker was appointed Director at Israel Corporation Ltd. The precise official start date will follow in due course, as per an announcement made on March 13, 2019. His work experience includes the following roles Executive Chairman of the Board at Israel Chemicals Ltd., Chairman of the Board of the Soroka Medical Center Friends Association, Chairman of the Board at Golf Co Ltd., Heavy Industries and Real Estate divisions Manager at Clal Industries Ltd., Chief Executive Officer at Clal Electronic Industries Ltd., Military Secretary at the Israeli Prime Minister Office and Deputy Head of the Israeli Air force . He holds a Bachelors degree in Economics and Business Administration from Bar Ilan University and a Masters degree in Public Administration from Harvard University.
| Age | 61 |
| Phone | 972 3 684 4500 |
| Web | https://www.israelcorp.com |
Israel Corp Management Efficiency
The company has return on total asset (ROA) of 0.1735 % which means that it generated a profit of $0.1735 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.405 %, meaning that it generated $0.405 on every $100 dollars invested by stockholders. Israel Corp's management efficiency ratios could be used to measure how well Israel Corp manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Orna Peled | Bezeq Israeli Telecommunication | 45 | |
| Ehood Nisan | Elbit Systems | 51 | |
| Mali Baron | Bank Hapoalim | 66 | |
| JeanMichel Halfon | Teva Pharmaceutical Industries | 67 | |
| Haim Levy | Bank Leumi Le Israel | 77 | |
| Ronit Rokach | Bank Hapoalim | 61 | |
| Yehoshua Gleitman | Elbit Systems | 69 | |
| Amnon Dick | Bezeq Israeli Telecommunication | 64 | |
| Joseph Nitzani | Teva Pharmaceutical Industries | 70 | |
| Dalia Rabin | Elbit Systems | 66 | |
| Murray Goldberg | Teva Pharmaceutical Industries | 74 | |
| Nechemia Peres | Teva Pharmaceutical Industries | 60 | |
| Yitzhak Sharir | Bank Leumi Le Israel | 66 | |
| Moshe Many | Teva Pharmaceutical Industries | 85 | |
| Avraham Asheri | Elbit Systems | 77 | |
| Nir Zichlinskey | Bank Hapoalim | 49 | |
| Imri Tov | Bank Hapoalim | 76 | |
| Arie Belldegrun | Teva Pharmaceutical Industries | 65 | |
| Gerald Lieberman | Teva Pharmaceutical Industries | 72 | |
| Ammon Dick | Bank Hapoalim | 62 | |
| Dov Ninveh | Elbit Systems | 71 | |
Management Performance
| Return On Equity | 0.41 | |||
| Return On Asset | 0.17 |
Israel Corp Leadership Team
Elected by the shareholders, the Israel Corp's board of directors comprises two types of representatives: Israel Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Israel. The board's role is to monitor Israel Corp's management team and ensure that shareholders' interests are well served. Israel Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Israel Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Amnon Lion, Director | ||
| Johanan Locker, Director | ||
| Joshua Rosensweig, External Director | ||
| Avisar Paz, CEO | ||
| Yoav Doppelt, Chief Executive Officer | ||
| Yair Caspi, Director | ||
| Jacob Amidror, External & Independent Director | ||
| Maya Kaplan, Executive Vice President, General Counsel, Company Secretary | ||
| Zehavit Cohen, Director | ||
| Oded Degany, External Director | ||
| Ron Moskovitz, Director | ||
| Eran Sarig, Executive VP of Bus. Devel. and Strategy | ||
| Gideon Langholz, External Director | ||
| Maya AlschichKaplan, Gen VP | ||
| Natan Yalovsky, Acting CFO | ||
| Aviad Kaufman, Chairman of the Board | ||
| Dan Suesskind, Independent Director | ||
| Tali Michaud, Independent Director | ||
| Ovadia Eli, Chairman ORL | ||
| Idan Hizki, Sr Relations | ||
| Asher Grinbaum, COO Ltd | ||
| Shay Ohayon, Controller | ||
| Michael Bricker, Director | ||
| Ofer Alkalay, Internal Auditor | ||
| Sagi Kabla, Vice President - Finance |
Israel Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Israel Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.41 | |||
| Return On Asset | 0.17 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.34 % | |||
| Current Valuation | 18.11 B | |||
| Shares Outstanding | 7.7 M | |||
| Shares Owned By Insiders | 50.33 % | |||
| Shares Owned By Institutions | 16.04 % | |||
| Price To Book | 1.30 X | |||
| Price To Sales | 0.96 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Israel Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Israel Stock analysis
When running Israel Corp's price analysis, check to measure Israel Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Israel Corp is operating at the current time. Most of Israel Corp's value examination focuses on studying past and present price action to predict the probability of Israel Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Israel Corp's price. Additionally, you may evaluate how the addition of Israel Corp to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| CEOs Directory Screen CEOs from public companies around the world |